Aug 2026
Defining the underlying pathology of corticobasal syndrome using clinical features and biomarkers.
D. P. Vaughan, M. T. Jensen, R. Real et al.
· Brain : a journal of neurolo... · 0 citations
We have 2 of 229 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
This study provides Class II evidence that plasma NfL/p-tau217 discriminates patients with CJD from those with AD and Diagnosing AD with a single abnormal p-tau plasma biomarker risks misdiagnosing prion diseases as AD.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.